Stanisic, Sanja, Americo Cicchetti, Camillo Porta, Giuseppe Procopio, and Patrizia Berto. 2018. “Cost-Effectiveness of Cabozantinib in Second-Line Treatment of Metastatic Renal Cell Cancer (mRCC) in Italy”. Global and Regional Health Technology Assessment 5 (1). https://doi.org/10.33393/grhta.2018.434.